Telegram RegisterThe public register of Telegram
Telegram profile photo for 글로벌바이오아저씨

Channel

글로벌바이오아저씨

@choaz1

On this record: Growth · Engagement · Reactions · Posts · Citations · Telegram's recommendations · Cite this entry

7,109subscribers

-28 since we began measuring on 7 August 2026

Risers and fallers across the register · movement among entries of 3,162–10,000.

Register entry

Telegram ID-1001893729962
TypeChannel
Username@choaz1
CreatedBetween 1 October 2022 and 30 September 2023 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded7 August 2026
Last confirmed live6 September 2026
Measurements held10
Confirmed unchanged1 time, most recently 6 September 2026
On Telegramt.me/choaz1

Growth

7,1097,1377,1237 August 2026 — 7,137 subscribers8 August 2026 — 7,137 subscribers11 August 2026 — 7,133 subscribers14 August 2026 — 7,130 subscribers17 August 2026 — 7,133 subscribers24 August 2026 — 7,127 subscribers27 August 2026 — 7,124 subscribers30 August 2026 — 7,123 subscribers1 September 2026 — 7,118 subscribers6 September 2026 — 7,109 subscribers7 August 20266 September 2026
10 measurements spanning 30 days, net -28. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 7,105–7,141 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
6 Sept 2026, 15:407,109-9
1 Sept 2026, 19:337,118-5
30 Aug 2026, 02:247,123-1
27 Aug 2026, 09:037,124-3
24 Aug 2026, 09:567,127-6
17 Aug 2026, 15:447,133+3
14 Aug 2026, 06:567,130-3
11 Aug 2026, 07:217,133-4
8 Aug 2026, 06:417,137no change
7 Aug 2026, 16:467,137first reading

Engagement

28 posts held, back to 1 July 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 12 pages of Telegram’s post history, 20 posts per page.

ERR · 30 days
24.5%
avg views ÷ 7,109 subscribers
Avg views / post
1,740
7 posts measured
Reaction rate
0.445%
reactions ÷ views · ER floor
Posts in window
7
of 28 held

ERR is average views per post over the last 30 days divided by subscribers, the definition TGStat uses, so this figure is comparable with the one you will see elsewhere. It falls structurally as a channel grows: a high ERR on a small channel and a low one on a large channel describe reach mathematics, not quality. We publish the figure and the sample it came from and pass no verdict on it.

ER is defined industry-wide as (forwards + reactions + comments) ÷ views — note the denominator is views, not subscribers. Telegram’s public web preview carries views and reactions but not forward or comment counts, so the reaction rate above is the reactions term only and is therefore a floor: the true ER for this channel is higher by an amount we have not measured and will not estimate. It is computed over the 4 of 7 measured posts that carry a reaction reading, and over those same posts' views.

What these figures were computed from
WindowRolling 30 days · latest post in window 20 August 2026
Posts held28 (1 July 202620 August 2026)
Views total12,188
Reactions total27
Forwards / commentsnot exposed by the public surface — not measured, not estimated
Readings taken20 Aug 2026, 15:17 UTC

Views are a single reading per post, taken at the time above. A post published in the last day or two is still accumulating views, which pulls the 30-day average down slightly. That is a property of the standard definition rather than a fault in it, so we keep the definition rather than “correcting” the number into something nobody can reproduce.

Precision. Telegram publishes view counts on its public widget in short form — 8.12K, 3.7M — so any reading at or above 1,000 reaches us rounded to three significant figures, and only counts below 1,000 are exact. Averages and rates derived from them are shown to the same precision rather than to the unit: a figure like 3,701,250 would assert digits nobody measured.

Reaction counts are published per emoji and rounded the same way, so a total below 1,000 is exact and a larger one is a sum that may carry a rounded component from each emoji above 1,000. Because it is a sum, it does not look rounded — read a large reaction total as three significant figures per contributing emoji rather than as the figure it prints.

Reaction mix

73 reactions across 17 posts, in 7 distinct kinds. The most used accounts for 41.1% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
👍3041.1%
2737.0%
🤔68.22%
🥰68.22%
😢22.74%
👌11.37%
🤯11.37%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 19 of the 28 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 73 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 28 most recent posts we hold, published 1 July 2026 to 20 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

20 Aug 2026, 00:44 UTC948 views2 reactionsread 20 August 2026

https://n.news.naver.com/article/018/0006354521?sid=105

👍2

19 Aug 2026, 11:11 UTC≈1,290 viewsread 20 August 2026
Forwarded from @BBAinsights

머크와 모더나가 mRNA 암 백신으로 흑색종 재발 위험을 유의미하게 낮추며 가속 승인을 추진합니다. 머크와 모더나가 공동 개발 중인 개인 맞춤형 mRNA 암 백신이 고위험 흑색종 환자를 대상으로 한 임상 3상 시험에서 재발 위험을 유의미하게 낮추는 데 성공했습니다. 이 연구는 수술적 절제를 마친 1,137명의 IIB-IV기 흑색종 환자를 대상으로 진행되었으며, 무재발 생존율(RFS)에서 통계적으로 유의미한 개선을 보였습니다. 환자군은 맞춤형 신생항원 치료제 intismeran autogene와 키트루다를 병용 투여한 그룹과 키트루다 단독 투여 그룹으로 나뉘어 비교되었습니다. 병용 투여군은 RFS뿐만 아니라 원격 전이 무생존율에서도 대조군 대비 우월한 결과를 도출했습니다. 안전성 측면에서도 새로운 이상 징후는 발견되지 않았습니다. 머크와

19 Aug 2026, 01:25 UTC≈1,540 views17 reactionsread 20 August 2026

[오름테라퓨틱.. 좋은 소식 들려오기를..]

👍122🤔2🤯1

16 Aug 2026, 11:15 UTC≈1,940 views4 reactionsread 20 August 2026
Forwarded from @growthbio

🧬돈 냄새 맡았다...K바이오 사모으는 '글로벌 큰손' https://n.news.naver.com/article/014/0005562107 💊 HLB 블랙록은 지난 3월 지분 5.01%를 처음 공시한 뒤 6월 6.05%, 이번 달 7.15%까지 끌어올림. 이달에만 147만주를 추가 확보하면서 총 보유 주식은 952만6000주로 증가 💊 유한양행(000100) 6월 지분 5.07% 신규 공시 이후 이달 74만6000주를 추가 매수해 지분율을 6.50%까지 확대. 총 보유 주식은 478만5000주 💊 알테오젠(196170) 이달 지분 5.03% 보유를 신규 공시하며 블랙록의 투자 대상에 새롭게 편입. 보유 주식은 269만4000주 💊 그 외 해외 자금 유입 사례 • 종근당(185750): 가치투자 성향의 미국 코페르닉 글로벌 인베스터

4

14 Aug 2026, 00:34 UTC≈1,640 views4 reactionsread 20 August 2026
Forwarded from @stoner8740

https://www.thebell.co.kr/front/newsview.asp?click=F&key=202608070316244390109260 #오름테라퓨틱 Orm6151 DAC 전세계 최초 임상 1상 약물, BMS가 잘 개발해 주고 있습니다.

4

12 Aug 2026, 01:06 UTC≈2,000 viewsread 20 August 2026
Forwarded from @thebio111

리보핵산(RNA) 간섭 기술 기반의 혁신신약 개발기업인 올릭스는 피하주사(SC) 또는 정맥주사(IV)로 투여한 작은 간섭 RNA(siRNA) 물질이 뇌의 깊은 부위를 포함한 다양한 뇌 영역에서 표적 유전자를 억제하는 것을 확인했다고 밝혔습니다. 올릭스의 원천 플랫폼인 ‘OASIS(OliX Advanced Small Interfering RNA System)-CNS’를 기반으로 기존에 확보한 CNS 표적 siRNA를 전신 투여형 물질로 확장한 결과로, 회사의 CNS 신약 개발이 플랫폼 구축을 넘어 실제 질환 치료제 개발 단계로 진전되고 있음을 보여줍니다. 올릭스는 siRNA에 뇌혈관장벽(BBB)을 통과할 수 있는 셔틀을 결합한 2세대 OASIS-CNS 플랫폼을 개발하고 있습니다. 이번 연구에서는 해당 물질을 생쥐에 피하 또는 정맥 투여한 결

10 Aug 2026, 00:23 UTC≈2,830 viewsread 20 August 2026

https://www.yakup.com/news/index.html?mode=view&pmode=&cat=all&cat2=&cat3=&nid=330846&num_start=0

8 Aug 2026, 00:44 UTC≈2,290 views1 reactionsread 20 August 2026
Forwarded from @global_biohealthcare_news

(빌 게이츠와 제프 베조스가 선택한 바이오텍: AI 진균 분석 플랫폼 보유한 LifeMine, $188M 투자유치) ================== LifeMine Therapeutics가 RA Capital와 MS 창업자 빌 게이츠, 아마존 창업자제프 베조스 등이 참여한 $188M 규모의 Series E 투자유치를 완료하였다. 이 회사는 작년 11월에 GSK, Google Ventures 등의 기존 주주로부터 $75M 규모의 Series D 투자유치를 한 바 있다. 주력 제품, LIFE-001은 장기 이식 후 면역 거부 반응을 억제하는 면역억제제이며, T세포 활성화 효소인 칼시뉴린(calcineurin)이 활성화되기 전 단계를 억제한다. 100명 이상의 건강 성인 대상 임상에서 독성 없이 우수한 면역 억제 효과를 보여주었다. 이 제

👍1

6 Aug 2026, 15:23 UTC≈1,610 views4 reactionsread 20 August 2026
Forwarded from @pharmbiohana

#이뮤노반트 #한올바이오파마 이번 업데이트의 핵심은 IMVT-1402의 6개 적응증 개발 일정이 모두 계획대로 진행 중이라는 점임. 현재 그레이브스병, 중증근무력증, CIDP, 난치성 류마티스관절염, 쇼그렌병, 피부홍반루푸스까지 동시에 개발 중임. 가장 가까운 이벤트는 2026년 하반기임. 난치성 류마티스관절염 추가 업데이트와 피부홍반루푸스 POC 톱라인 결과가 예정돼 있음. CLE 초기 사례에서는 첫 환자의 IgG가 78% 감소하고 CLASI-A가 64% 개선됐으며, 두 번째 환자도 12주차에 50% 이상 개선됨. 다만 아직 소수 사례라 전체 데이터 확인이 중요함. 2027년에는 그레이브스병과 MG, 2028년에는 CIDP와 쇼그렌병 톱라인이 예정돼 있어 데이터가 연속적으로 이어지는 구조임. https://www.immunovan

4

6 Aug 2026, 10:37 UTC861 views0 reactionsread 20 August 2026
Forwarded from @aprilbioiprPhoto

오는 9월 30일 EADV학회에서 APB-R3 2a상 탑라인 결과발표가 예정되어있습니다. 제목이 ‘positive’ data발표라는 점이 눈에 띕니다.

4 Aug 2026, 22:49 UTC≈1,980 views2 reactionsread 20 August 2026
Forwarded from @kkk595959

2026.08.05 07:41:35 기업명: 알테오젠(시가총액: 18조 5,945억) A196170 보고서명: 투자판단관련주요경영사항 (재조합 인간 히알루로니다제 제품 ALTB4 독점적 라이선스 계약 체결) 제목 : 재조합 인간 히알루로니다제 제품 ALT-B4 독점적 라이선스 계약 체결 * 주요내용 ※ 투자유의사항 본 계약은 의약품규제기관의 허가가 완료되어야 이행되는 조건부 계약으로서, 본 계약을 통한 수익 인식은 임상시험과 품목허가 등의 성공 여부에 따라 달라질 수 있습니다. 계약 조건에 따라, 규제기관에 의한 연구 개발의 중단, 품목허가 실패 등 발생시 계약이 해지될 수 있습니다. 1. 계약상대방: 비공개 2. 계약의 내용: 알테오젠의 하이브로자임 플랫폼 기반 재조합 인간 히알루로니다제 ALT-B4를 적용한

2

3 Aug 2026, 02:51 UTC≈1,900 views1 reactionsread 20 August 2026
Forwarded from @pharmbiohana

- 아스트라제네카와 BMS가 인수합병 가능성을 놓고 초기 논의를 진행한 것으로 알려짐 - 성사 시 합산 기업가치는 약 4,000억달러로, 제약·바이오 역사상 최대급 M&A 가능 - 아스트라제네카의 타그리소·임핀지·엔허투와 BMS의 옵디보 등 항암 포트폴리오 시너지 기대 - BMS는 특허절벽 이후 성장동력이 필요하고, 아스트라제네카는 미국 시장과 상업화 역량 확대가 목적 - 다만 아직 초기 단계이며, 항암 사업 중복에 따른 반독점 심사가 핵심 변수 - 이번 논의는 특허만료와 내부 R&D 한계로 빅파마들이 다음 성장축 확보에 상당히 급해졌다는 신호로 해석 가능 https://www.reuters.com/legal/litigation/astrazeneca-holds-talks-with-bristol-myers-squibb-potential-meg

1

Showing the 12 most recent of 28 posts we hold for @choaz1. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Appears in Telegram’s recommendations for other channels

The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.

Yeouido Lab_여의도 톺아보기
@Yeouido_Lab · 43,265
Telegram ranks this channel #35 of 90 here — alongside 89 others — read 2 September 2026
급등일보 미국주식🇺🇸 속보·매크로·리서치
@FastStockNewsUSA · 40,527
Telegram ranks this channel #37 of 89 here — alongside 88 others — read 2 September 2026
주식 급등일보🚀급등테마·대장주 탐색기 | Korean Stocks
@FastStockNews · 128,635
Telegram ranks this channel #58 of 92 here — alongside 91 others — read 2 September 2026
AWAKE - 실시간 주식 공시 정리채널
@darthacking · 65,037
Telegram ranks this channel #65 of 91 here — alongside 90 others — read 2 September 2026
YM리서치
@ym_research · 39,984
Telegram ranks this channel #67 of 89 here — alongside 88 others — read 2 September 2026
하나 중국/신흥국 전략 김경환
@HANAchina · 35,023
Telegram ranks this channel #71 of 92 here — alongside 91 others — read 2 September 2026
루팡
@bornlupin · 47,667
Telegram ranks this channel #76 of 91 here — alongside 90 others — read 2 September 2026
타점 읽어주는 여자(타자)
@tazastock · 40,053
Telegram ranks this channel #78 of 89 here — alongside 88 others — read 2 September 2026
재야의 고수들
@gaoshoukorea · 41,194
Telegram ranks this channel #81 of 90 here — alongside 89 others — read 2 September 2026
그로쓰리서치(Growth Research) [독립리서치]
@growthresearch · 40,119
Telegram ranks this channel #82 of 90 here — alongside 89 others — read 2 September 2026
시장 이야기 by 제이슨
@bumgore · 35,261
Telegram ranks this channel #83 of 89 here — alongside 88 others — read 2 September 2026
여의도스토리 Ver2.0-习近平是个狗东西
@YeouidoStory2 · 58,406
Telegram ranks this channel #84 of 92 here — alongside 91 others — read 2 September 2026
실시간 주식 뉴스
@realtime_stock_news · 37,286
Telegram ranks this channel #87 of 93 here — alongside 92 others — read 2 September 2026
에테르의 일본&미국 리서치
@aetherjapanresearch · 34,311
Telegram ranks this channel #88 of 89 here — alongside 88 others — read 3 September 2026

This channel appears in 14 seed channels' Telegram-generated recommendation lists in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 6 September 2026 — this entry's latest reading, not the date you are reading this.

“글로벌바이오아저씨” (@choaz1), 7,109 subscribers as measured 6 September 2026. Telegram Register, tgregister.com/channel/choaz1.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.